Tailings – what’s left after mined ores are fully processed – is today a global liability. But there are tens of billions of dollars of material value tied up in those tailings. Why not turn them into a revenue opportunity? MIT researchers, and newly spun-out startup companies, are hard at work on inventing, developing, and scaling up technologies that will enable this transition. Join us on November 18th to learn more about this impactful work!
Over the past decade, research on the development of multi-cellular engineered living systems has produced technologies and capabilities that are now positioned to facilitate a fundamental understanding of disease processes and can help to identify innovative therapeutic strategies. Globally, while many labs are engaged in the development of new and more sophisticated organ models for drug discovery and screening, there is an urgent need to disrupt the way drugs are currently developed. Our vision is to humanize drug development based on a new approach that integrates microphysiological system models of disease and enhanced model control/interrogation, with modern systems biology and systems immunology. This is the focus of Living Machines, one of five threads in the New Engineering Education Transformation (NEET) program to reimagine engineering education at MIT in which sophomores, juniors and seniors, under the guidance of faculty mentors and instructors, learn, discover, build and engineer living systems for broad applications in biotechnology and medical devices. This webinar will share the perspectives of 3 MIT faculty, their research capabilities and interests in which NEET students can participate, and that of several NEET students and what they can or hope to achieve.
How can small molecules be identified that evoke cell or tissue regeneration by design? How can we engineer cells and tissue-growth in situ with a structure suitable for implantation? How can we physically gain access to the interior of cells for both discovery and engineering purposes? And how can the immune system be mapped with single-cell biology to accelerate discovery?
Contact
This fall, MIT’s Industrial Liaison Program (ILP) and Energy Initiative (MITEI) will continue the energy innovation webinar series focused on the energy transition. The series will further engage leading researchers from across MIT and industry executives on topics including power markets, low-carbon fuels, decarbonization of buildings and industry, and other sectors. Industrial collaboration has long been a hallmark of MIT’s approach to problem solving. Please join us to hear what we are doing together with our industrial partners to address the climate change challenges.
In this webinar, Paul Joskow, a professor of economics, Johannes Pfeifenberger, a visiting scholar, and Cheryl Lafleur, a former FERC member, reflect on the recent large-scale power outages in California; the combined risks from natural disasters, such as forest fires; and the growing supply intermittency associated with increasing solar and wind generation. Robert Stoner, the deputy director for science and technology at MITEI, will moderate and lead an audience Q&A.